Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126969601 | 12696960 | 1 | I | 20150819 | 20160830 | 20160830 | EXP | US-ROCHE-1623832 | ROCHE | 0.00 | M | Y | 94.00000 | KG | 20160830 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126969601 | 12696960 | 1 | PS | ESBRIET | PIRFENIDONE | 1 | Oral | 3 CAPSULES 3 TIME A DAY | U | 22535 | 801 | MG | CAPSULE | TID | |||||
| 126969601 | 12696960 | 2 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | 2 CAPSULES 3 TIME A DAY | U | 22535 | 534 | MG | CAPSULE | TID | |||||
| 126969601 | 12696960 | 3 | SS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Unknown | U | 21087 | ||||||||||
| 126969601 | 12696960 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0 | .5 | MG | TABLET | TID | |||||||
| 126969601 | 12696960 | 5 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 126969601 | 12696960 | 6 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Oral | 0 | 8 | MG | TABLET | ||||||||
| 126969601 | 12696960 | 7 | C | ACETAMINOPHEN/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | Oral | 5-325 MG | 0 | TABLET | |||||||||
| 126969601 | 12696960 | 8 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Unknown | 0 | 750 | MG | |||||||||
| 126969601 | 12696960 | 9 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | TABLET | ||||||||
| 126969601 | 12696960 | 10 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 0 | 60 | MG | Q8H | ||||||||
| 126969601 | 12696960 | 11 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | TABLET | Q6H | |||||||
| 126969601 | 12696960 | 12 | C | ALBUTEROL/IPRATROPIUM | ALBUTEROLIPRATROPIUM | 1 | Unknown | 0.5- 2.5 MG | 0 | QID | |||||||||
| 126969601 | 12696960 | 13 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 325 | MG | TABLET | QD | |||||||
| 126969601 | 12696960 | 14 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 126969601 | 12696960 | 15 | C | BISACODYL. | BISACODYL | 1 | Rectal | 0 | 10 | MG | SUPPOSITORY | QD | |||||||
| 126969601 | 12696960 | 16 | C | ENOXAPARIN | ENOXAPARIN | 1 | Subcutaneous | AT NIGHT | 0 | 40 | MG | QD | |||||||
| 126969601 | 12696960 | 17 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 0 | 20 | MG | TABLET | BID | |||||||
| 126969601 | 12696960 | 18 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 126969601 | 12696960 | 19 | C | GUAIFENESIN. | GUAIFENESIN | 1 | Oral | 0 | 200 | MG | TABLET | QD | |||||||
| 126969601 | 12696960 | 20 | C | ONDANSETRON | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 0 | 4 | MG | Q6H | ||||||||
| 126969601 | 12696960 | 21 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | Oral | 0 | 12.5 | MG | |||||||||
| 126969601 | 12696960 | 22 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | Oral | 0 | 17 | MG | QD | ||||||||
| 126969601 | 12696960 | 23 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 12.5 | MG | Q6H | ||||||||
| 126969601 | 12696960 | 24 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
| 126969601 | 12696960 | 25 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | |||||||||
| 126969601 | 12696960 | 26 | C | ALUMINUM HYDROXIDE/MAGNESIUM HYDROXIDE/SIMETHICONE | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | Oral | 200-20/5 MG | 0 | Q4H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126969601 | 12696960 | 1 | Idiopathic pulmonary fibrosis |
| 126969601 | 12696960 | 3 | Product used for unknown indication |
| 126969601 | 12696960 | 4 | Anxiety |
| 126969601 | 12696960 | 19 | Cough |
| 126969601 | 12696960 | 20 | Nausea |
| 126969601 | 12696960 | 21 | Constipation |
| 126969601 | 12696960 | 23 | Nausea |
| 126969601 | 12696960 | 26 | Dyspepsia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126969601 | 12696960 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126969601 | 12696960 | Abdominal pain upper | |
| 126969601 | 12696960 | Acute respiratory failure | |
| 126969601 | 12696960 | Anxiety | |
| 126969601 | 12696960 | Idiopathic pulmonary fibrosis | |
| 126969601 | 12696960 | Prostate infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |